Amphastar Pharmaceuticals
AMPH
#5558
Rank
NZ$2.15 B
Marketcap
NZ$46.34
Share price
-1.40%
Change (1 day)
-37.48%
Change (1 year)

Market capitalization of Amphastar Pharmaceuticals (AMPH)

Market cap: NZ$2.15 Billion

As of December 2025 Amphastar Pharmaceuticals has a market cap of NZ$2.15 Billion. This makes Amphastar Pharmaceuticals the world's 5558th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amphastar Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$2.15 B-33.14%
2024NZ$3.22 B-31.22%
2023NZ$4.68 B119.66%
2022NZ$2.13 B30.74%
2021NZ$1.63 B23.25%
2020NZ$1.32 B-0.77%
2019NZ$1.33 B-3.57%
2018NZ$1.38 B11.07%
2017NZ$1.24 B1.77%
2016NZ$1.22 B30.23%
2015NZ$0.93 B42.05%
2014NZ$0.66 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Amphastar Pharmaceuticals was reported to be:

NZ$2.12 Billion
by Nasdaq info icon info icon
NZ$2.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Marinus Pharmaceuticals
MRNS
NZ$52.57 M-97.56%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
NZ$47.62 M-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
NZ$18.04 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Tonix Pharmaceuticals
TNXP
NZ$0.40 B-81.42%๐Ÿ‡บ๐Ÿ‡ธ USA